✦ LIBER ✦

476 Serum Proteomic Classification in Refractory Non-small-cell Lung Cancer Treated with Erlotinib +/− Pazopanib in a Randomized Placebo-controlled Phase II Study

✍ Scribed by Spigel, D.R.; Burris, H.A.; Greco, F.A.; Lipman, A.J.; Waterhouse, D.M.; Daniel, D.B.; Ma, Z.; Arkenau, H.T.; Grigorieva, J.; Hainsworth, J.D.

Book ID: 122714141
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 73 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(12)72274-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase II Study of Erlotinib P

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non-Small-Cell Lung Cancer

✍ Sequist, L. V.; von Pawel, J.; Garmey, E. G.; Akerley, W. L.; Brugger, W.; Ferra 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 205 KB

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer

✍ Spigel, D. R.; Burris, H. A.; Greco, F. A.; Shipley, D. L.; Friedman, E. K.; Wat 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 161 KB

Randomized, Placebo-Controlled Phase II

Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non Small-Cell Lung Cancer

✍ Heymach, J. V.; Johnson, B. E.; Prager, D.; Csada, E.; Roubec, J.; Pesek, M.; Sp 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 209 KB

Randomized, Placebo-Controlled, Phase II

Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

✍ Mok, T. S.K.; Wu, Y.-L.; Yu, C.-J.; Zhou, C.; Chen, Y.-M.; Zhang, L.; Ignacio, J 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 151 KB

Erlotinib as maintenance treatment in ad

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study

✍ Federico Cappuzzo; Tudor Ciuleanu; Lilia Stelmakh; Saulius Cicenas; Aleksandra S 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 321 KB

A phase II study of bevacizumab and erlo

A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluation

✍ Akerley, Wallace; Boucher, Kenneth; Rich, Nathan; Egbert, Lyle; Harker, Graydon; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 282 KB